摘要
目的 :探讨女性性乳腺癌患者血清 PSA (前列腺特异性抗原 )的含量及其临床意义。方法 :应用微粒子化学发光酶免疫技术测定正常对照组、良性对照组及乳腺癌患者术前术后血清 PSA的含量。结果 :女性乳腺癌患者术前血清 PSA的含量明显高于对照组 (P<0 .0 5 ) ,而术后明显下降 ,良性对照组比较差异无显著意义 (P>0 .0 5 )。结论 :检测女性乳腺肿瘤疾病患者血清 PSA的含量 ,有助于乳腺癌的诊断及治疗观察。
Objective:To study the serum PSA levels and clinical value in patients with breast cancer.Methods:The contents of serum PSA in the healthy women,the women with the primary breast tumors and the preoperative or the postoperative of breast cancer,were detected by applying fully automatic immunoassay of micro particle chemiluminescence enzyme.Results:The preoperative serum PSA levels of breast cancer patients were much higher than those of the control group( P< 0.05),while the postoperative serum PSA levels were dropped markedly.There was not significant difference between the healthy women and primary breast tumors( P> 0.05).Conclusions:Detecting the serum PSA levels in patients with breast tumors will be helpful to judge breast cancer and curative efficacy.
出处
《现代预防医学》
CAS
2003年第3期345-346,共2页
Modern Preventive Medicine